Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
B. Lynne Parshall currently holds 10,784 shares of IONIS PHARMACEUTICALS INC (IONS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, B. Lynne Parshall has been a net seller of IONS stock. They have purchased $3.0M and sold $52.0M worth of shares.
B. Lynne Parshall's most recent insider trade was on Sep 1, 2026, when they sold 5,000 shares at $71.48 per share.
B. Lynne Parshall serves as Executive at IONIS PHARMACEUTICALS INC (IONS). They have executed 425 insider transactions totaling $55.0M over their tenure at the company.
B. Lynne Parshall holds the position of Executive at IONIS PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
B. Lynne Parshall has shown a selling trading pattern, with $3.0M in total purchases and $52.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by B. Lynne Parshall was on Dec 27, 2023, when they sold $2.5M worth of IONS shares. This transaction involved 50,000 shares at $50.23 per share.
B. Lynne Parshall currently owns 10,784 shares of IONIS PHARMACEUTICALS INC (IONS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of B. Lynne Parshall's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. B. Lynne Parshall has 425 Form 4 filings on record as an insider at IONIS PHARMACEUTICALS INC.
Set alerts for B. Lynne Parshall and 40,000+ other insiders.